Vaginal condition treatment update: Men should get treated, too

Recent updates from the American College of Obstetricians & Gynecologists (ACOG) emphasize the importance of treating both partners in cases of bacterial vaginosis (BV). New evidence suggests that addressing the condition effectively requires a dual approach, where male partners receive treatment alongside women. This includes administering an oral antibiotic and applying a topical antibiotic cream to the male genital area. Dr. Christopher Zahn, ACOG's chief of clinical practice and health equity, noted that partner therapy could play a vital role in preventing the recurrence of BV and enhancing patient comfort more swiftly. BV, which affects nearly 30% of women globally, can be both embarrassing and stigmatizing due to its symptoms, including itching, burning, an unpleasant fishy odor, and abnormal vaginal discharge. Though often perceived as an infection, bacterial vaginosis is actually a disruption in the natural balance of bacteria in the vagina, a condition known as dysbiosis. This imbalance can be notoriously challenging to resolve; studies indicate that up to 66% of women may experience a recurrence after treatment. Dr. Zahn highlighted the significant distress caused by BV, which can disrupt daily life and lead to frustration when symptoms persist. Recent research has shed light on the factors contributing to BV recurrence. While it is not classified as a sexually transmitted infection, BV shares some characteristics with them, such as associations with new sexual partners and similar incubation periods. Furthermore, certain bacterial communities found in male partners can harbor the strains linked to BV, suggesting that their microbial health may influence the risk of recurrence for their female partners.